Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial
Abstract Background As of mid-June 2020, 7,500,000 people were infected with SARS-CoV-2 worldwide and 420,000 people died, mainly from coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). COVID-19-related ARDS is subject to a mortality rate of 50% and prolonged per...
Main Authors: | Aurélien Mazeraud, Bruno Gonçalves, Philippe Aegerter, Letizia Mancusi, Christine Rieu, Fernando Bozza, Khaoussou Sylla, Shidasp Siami, Tarek Sharshar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05118-7 |
Similar Items
-
Some geometric aspects of polyvalent systems modeling
by: Irus Grinis, et al.
Published: (2012-12-01) -
Recent formulation for polyvalent Clostridial vaccine
by: Roukaia M. Osman, et al.
Published: (2010-12-01) -
La polyvalence administrative postale en milieu rural
by: Gilles PANNETIER
Published: (1991-09-01) -
Selection of polyvalent bacteriophages infecting Salmonella enterica serovar Choleraesuis
by: Bárbara Parra, et al.
Published: (2016-05-01) -
Phage S144, A New Polyvalent Phage Infecting <i>Salmonella</i> spp. and <i>Cronobacter sakazakii</i>
by: Michela Gambino, et al.
Published: (2020-07-01)